Clinical Trial Update: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Zeprumetostat and Azacitidine in combination with Lipo-MIT for relapsed/refractory peripheral T-cell lymphoma is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lipo-MIT
• Zeprumetostat (zeprumetostat)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Peripheral T Cells Lymphoma (PTCL) | Phase 2 | Status: RECRUITING